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Am J Physiol Renal Physiol 308: F689–F696, 2015. First published
January 21, 2015; doi:10.1152/ajprenal.00417.2014.—Maternal smoking is
associated with metabolic disorders, renal underdevelopment, and a
predisposition to chronic kidney disease in offspring, yet the under-
lying mechanisms are unclear. By exposing female Balb/c mice to
cigarette smoke for 6 wk premating and during gestation and lactation,
we showed that maternal smoke exposure induced glucose intoler-
ance, renal underdevelopment, inflammation, and albuminuria in male
offspring. This was associated with increased renal oxidative stress
and mitochondrial dysfunction at birth and in adulthood. Importantly,
we demonstrated that dietary supplementation of L-carnitine, an amino
acid shown to increase antioxidant defenses and mitochondrial func-
tion in numerous diseases, in smoke-exposed mothers during preg-
nancy and lactation significantly reversed the detrimental maternal
impacts on kidney pathology in these male offspring. It increased
SOD2 and glutathione peroxidase 1, reduced ROS accumulation, and
normalized levels of mitochondrial preprotein translocases of the
outer membrane, and oxidative phosphorylation complexes I–V in the
kidneys of mouse progeny after intrauterine cigarette smoke exposure.
These findings support the hypothesis that oxidative stress and mito-
chondrial dysfunction are closely linked to the adverse effects of
maternal smoking on male offspring renal pathology. The results of
our study suggest that L-carnitine administration in cigarette smoke-
exposed mothers mitigates these deleterious renal consequences.
chronic kidney disease; reactive oxidative species; mitochondria
MATERNAL CIGARETTE SMOKING during pregnancy is a well-rec-
ognized causative factor for intrauterine growth retardation (2)
associated with the underdevelopment of fetal/neonatal tissues
(24), including the kidney (29). We have recently demonstrated
that maternal cigarette smoke exposure (SE) decreased kidney
weight and delayed nephron formation and maturation as well
as increased the urinary albumin-to-creatinine ratio at adult-
hood in male offspring (1). With the underlying mechanisms
not fully understood, we hypothesized that increased oxidative
stress and mitochondrial dysfunction are closely involved in
these adverse kidney outcomes.
Living organisms are constantly exposed to oxidants from
endogenous metabolic processes, such as ROS, a group of
O2-derived byproducts released during mitochondrial oxidative
phosphorylation (OXPHOS) to generate ATP. Oxidative stress
occurs when intracellular antioxidants are unable to counteract
the overproduction of ROS, leading to irreversible oxidative
modifications to all cellular components, including lipid, pro-
tein, and DNA, thus affecting cell structure, function, and
viability (26). Smoking has been regarded as a major cause of
elevated oxidative stress in active and passive smokers (16).
Maternal smoking during pregnancy cannot only induce severe
oxidative stress in the mother but also in offspring (11, 25), due
to the diffusion of free radicals and harmful chemicals within
cigarette smoke (e.g., nicotine) through the blood-placental
barrier into the fetus (18). This impact, however, has been only
scarcely studied in neonatal plasma and urine and rarely in
neonatal organs (such as the kidney). We hypothesized that
maternal cigarette smoke exposure (SE) can increase oxidative
stress in newborn kidneys, which persists until adulthood.
As the major source of ROS, the mitochondrion is the most
affected organelle by oxidative stress. As the cellular power-
house, impaired mitochondria can fatally imperil energy me-
tabolism and cell viability (26). Therefore, oxidative stress-
associated mitochondrial damage and dysfunction have been
implicated in a number of diseases, such as type 2 diabetes (20)
as well as cancer and neurodegenerative disease (9). Impor-
tantly, such oxidative damage is likely to result in permanent
modifications in mitochondrial DNA, which can be maternally
inheritable. This potentially increases the risk of these disor-
ders being transmitted to the progeny. Oxidative damage to
mitochondrial DNA has been found in fetuses and infants
whose mothers were exposed to cigarette smoke or nicotine
during pregnancy (4, 25), suggesting a possible impact of
maternal smoking on mitochondrial function in offspring.
However, the effect on kidney function has not yet been
explored.
Carnitine, mainly synthesized in the liver and kidney, is
essential for mitochondrial fatty acid metabolism (21). Supple-
mentation of L-carnitine (LC), the active form of carnitine, and
its derivatives has been shown to attenuate oxidative stress and
mitochondrial dysfunction in diverse conditions, such as age-
related disorders and chronic heart failure (15, 19). In patients
with end-stage kidney disease requiring dialysis, LC therapy
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has been shown to restore plasma antioxidant/oxidant homeo-
stasis (13). However, as in most studies in patients with
end-stage kidney disease, well-established pathology is un-
likely to be reversed, independent of the inciting mechanism.
The present study aimed to examine the utility of maternal LC
supplementation after conception to reverse or ameliorate ma-
ternal SE-induced renal oxidative stress and mitochondrial
dysfunction in male offspring.
MATERIALS AND METHODS
Animal experiments. The study was approved by the Animal Care
and Ethics Committee of the University of Sydney. The Guide for the
Care and Use of Laboratory Animals (National Institutes of Health)
were followed. Female Balb/c mice (8 wk) were divided into the
following three groups: sham (exposed to air), SE [2 cigarettes twice
daily, 6 wk before mating and throughout gestation and lactation, as
previously described (1)], and SE  LC [SE mothers supplied with
LC (1.5 mM in drinking water) during gestation and lactation]. The
LC dose and administration were adapted from a previous study (28).
Male breeders and suckling pups stayed in the home cage when
mothers were exposed to sham or SE conditions. All offspring studied
were male. Offspring were euthanized at postnatal day 1 (P1),
weaning age [postnatal day 20 (P20)], and mature age (week 13). An
intraperitoneal glucose tolerance test was performed on week 12 as
previously described (6). Blood, urine, and kidneys were collected for
further analysis.
Kidney histology. Kidney samples from male offspring were em-
bedded in paraffin and sectioned in 2-m slices. Kidney structure was
examined using hematoxylin and eosin and periodic acid-Schiff stain.
Glomerular number and size were quantitated as per our previous
protocol (1).
Real-time PCR. Kidney total RNA was extracted and purified using
TRIzol Reagent (Life Technology), from which cDNA was synthe-
sized using a Transcriptor First Strand cDNA Synthesis Kit (Roche
Diagnostics, Mannheim, Germany). Real-time PCR was performed
using preoptimized SYBR green primers (Sigma-Aldrich) and RT-
PCR master mix (Life Technology) to assess mRNA expression levels
of macrophage chemoattractant protein (MCP)-1 in the kidney, with
18S rRNA as the housekeeping gene.
ELISA. Levels of urinary albumin and creatinine, serum insulin,
and cotinine were measured using a Murine Microalbuminuria ELISA
kit (Albuwell M), Creatinine Companion Kit (Exocell), Insulin
(Mouse) ELISA Kit (Abnova, Taipei, Taiwan), and cotinine ELISA
Kit (Abnova), respectively, as per the manufacturers’ instructions.
Western blot analysis SOD assay. Frozen kidneys were homoge-
nized in HEPES buffer (20 mM, pH 7.2, containing 1 mM EGTA, 210
mM mannitol, and 70 mM sucrose). The homogenate was centrifuged
to isolate cytosolic and mitochondrial fractions. Protein concentra-
tions were determined and stored at 80°C for further analysis.
Proteins were electrophoresed and electroblotted to Hybond nitro-
cellulose membranes (Amersham Pharmacia Biotech). Membranes
were incubated in one of the following primary antibodies: anti--
actin (Santa Cruz Biotechnology), goat anti-glutathione peroxidase
(GPx)-1 (R&D Systems), rabbit anti-MnSOD (Millipore), rabbit anti-
translocase of the outer membrane 20 (TOM20; Santa Cruz Biotech-
nology), and mouse anti-OXPHOS complex I–V cocktail (Abcam)
and then horseradish peroxidase-conjugated secondary antibody.
Blots were developed with Luminata Western HRP Substrates (Mil-
lipore) by ImageQuant LAS 4000 (Fujifilm, Tokyo, Japan). Mem-
branes were restored by stripping buffer (Thermo Scientific) after-
ward. ImageJ (National Institutes of Health) was used for densitom-
etry, and -actin was used as the housekeeping protein.
A Superoxide Dismutase Assay Kit II (Millipore) was used to
measure mitochondrial SOD activity in isolated mitochondrial pro-
teins according to the manufacturer’s instructions.
Confocal microscopy. For ROS detection, CellROX deep red (5
M, Molecular Probes) was used, and images were collected at an
excitation wavelength of 633 nm and detected in the emission range
of 640–680 nm. MitoTracker green FM (200 nM, Molecular Probes)
was used to visualize the mitochondria, and images were collected at
an excitation wavelength of 458 nm and detected in the emission
range of 480–505 nm. Multiple images were taken for over 100 cells
in each tissue in 3 replicates of 3 independent samples/group. Mor-
phological features were quantified using a confocal laser scanning
microscope (Leica TCS SP2 X, Leica, Wetzlar, Germany). All imag-
ing parameters, including laser intensities, photomultiplier tube volt-
age, and the pinhole, were kept constant during imaging. The tissue
segmentation method was used for data analysis as previously de-
scribed by Bagett et al. (3) and confirmed using a common threshold
units for all images. Data are expressed as mean fluorescent intensi-
ties. To calculate the correlation between CellROX and Mitotracker,
dual staining using CellRox and Mitotracker was performed, and
images were taken sequentially using separate confocal channels over
a time not greater than 30 s. The image pixel intensity value correla-
tion was then calculated using Pearson’s correlation for all pixels
excluding any pairs containing zero values.
Statistical analysis. One-way ANOVA followed by Fisher least-
significant-difference post hoc tests was used to determine differences
between groups (Prism 6, GraphPad). Data are expressed as means 
standard errors. P values of 0.05 were considered as statistically
significant.
RESULTS
Maternal LC supplementation normalized birth weight and
kidney weight in SE offspring. Body weight and kidney mass
were significantly reduced in SE offspring at birth (P1, P 
0.05; Table 1). This is consistent with human studies (7, 29)
and supports the relevance of this mouse model for studying
the effect of maternal SE on renal disorders in offspring. LC
supplementation reversed the phenotype of low birth weight
and kidney weight in P1 SE offspring to control levels (SE 
LC group; Table 1).
Maternal LC supplementation normalized renal phenotype
and glucose tolerance in SE offspring. There were significant
delays in kidney development in SE offspring until adulthood.
Table 1. Body and kidney weights of offspring
Control Group SE Group SE  LC Group
P1
Body weight, g 1.55 0.05 1.35 0.06* 1.58 0.06†
Kidney weight, g 0.0081 0.0004 0.0069 0.0004* 0.0086 0.0010†
Kidney weight/
body weight, % 0.52 0.02 0.51 0.04 0.55 0.04
P20
Body weight, g 9.97 0.16 9.71 0.14 9.74 0.43
Kidney weight, g 0.067 0.001 0.062 0.003 0.067 0.002
Kidney weight/
body weight, % 0.67 0.01 0.062 0.03 0.70 0.03
Week 13
Body weight, g 25.5 0.3 25.1  0.6 25.3  0.3
Kidney weight, g 0.20 0.01 0.19 0.01 0.19 0.01
Kidney weight/
body weight, % 0.77 0.01 0.76 0.02 0.77 0.02
Values are means  standard errors; n  6–10. Offspring from the
following three groups are shown: sham (mothers exposed to air), smoke
exposed (SE; mothers exposed to 2 cigarettes twice daily, 6 wk before mating
and throughout gestation and lactation), and SE  LC [SE mothers supplied
with L-carnitine (LC; 1.5 mM in drinking water) during gestation and lacta-
tion]. P1, postnatal day 1; P20, postnatal day 20. *P  0.05 vs. the control
group; †P  0.05 vs. the SE group.
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The average number of glomeruli was approximately half of
the control (P  0.05), whereas glomerular size was increased
at weaning (P  0.05) but reduced in adulthood (P  0.01;
Fig. 1, A and B). This was associated with a significant increase
in renal MCP-1 mRNA expression in SE offspring (P  0.01;
Fig. 1C). The urinary albumin-to-creatinine ratio was also
significantly higher in the SE group at week 13. In addition,
offspring from SE mothers had normal serum insulin levels
(Table 2) but were glucose intolerant (Fig. 1D), suggestive of
impaired pancreatic insulin secretion.
In contrast, SE offspring of LC-treated mothers showed an
improvement in histological and metabolic parameters. Glo-
merular number and size were normalized (Fig. 1, A and B),
and glucose tolerance returned to the level of the control group
(Fig. 1, C and D). Renal MCP-1 mRNA expression and the
urinary albumin-to-creatinine ratio were no longer significantly
different from those observed in control animals. Serum coti-
nine levels were increased in both SE and SE  LC groups,
confirming cigarette SE (Table 2).
Maternal LC supplementation alleviated renal oxidative
stress in SE offspring. MnSOD and GPx-1 were measured as
representative markers for antioxidative defense, as each is
involved in one of the two-step ROS converting reaction
(O2 ¡ H2O2 ¡ H2O  O2). In addition, both mitochondrial
and cytosolic fractions were measured to determine which
fraction was more susceptible to damage and whether changes
were due to altered gene expression or protein translocation
between the cytoplasm and mitochondria. At P1, all measured
renal antioxidant markers, including mitochondrial MnSOD,
cystolic MnSOD, mitochondrial GPx-1, and cytosolic GPx-1,
were significantly reduced in SE offspring by 40% (P  0.01),
50%, 60%, and 70% (P  0.001), respectively, suggesting a
broad adverse effect of maternal SE on renal antioxidant
capacity (Fig. 2A). However, only cytosolic MnSOD (P 0.05;
Fig. 2C) and mitochondrial MnSOD (P  0.05; Fig. 2E) were
significantly lower than control levels at P20 and week 13,
Fig. 1. Impaired renal development, inflammation, and glucose intolerance in male smoke-exposed (SE) offspring. Offspring from the following three groups
are shown: sham (mothers exposed to air), SE (mothers exposed to 2 cigarettes twice daily, 6 wk before mating and throughout gestation and lactation), and SE  LC
[SE mothers supplied with L-carnitine (LC; 1.5 mM in drinking water) during gestation and lactation]. A and B: average glomerular number (A) and glomerular
size (B) of offspring kidneys at postnatal day 1 (P1), postnatal day 20 (P20), and week 13. C: renal mRNA expression of macrophage chemoattractant protein
(MCP)-1 at week 13. D: intraperitoneal glucose tolerance test (IPGTT) at week 13. AUC, area under the curve. *P  0.05; **P  0.01.
Table 2. Blood levels of cotinine and insulin and the urinary
albumin-to-creatinine ratio at week 13
Control Group SE Group SE  LC Group
Cotinine, ng/ml 1.35  0.60 3.90 0.42† 4.48 0.17†
Insulin, ng/ml 0.53  0.02 0.54 0.01 0.54 0.01
Albumin-to-creatinine ratio 43.0 14.0 104.7 19.6* 81.5 32.5
Values are means  standard errors; n  6–10. *P  0.05 and †P  0.01
vs. the control group.
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Fig. 2. Renal antioxidant capacity in offspring. A, C, and E: renal mitochondrial and cytosolic MnSOD and glutathione peroxidase (GPx)-1 levels at P1 (A), P20
(C), and week 13 (E). B, D, and F: MnSOD activity at P1 (B), P20 (D), and week 13 (F). n  4–8. *P  0.05; **P  0.01; ***P  0.001.
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respectively, without any changes of GPx-1 at either time point,
suggesting renal oxidative stress by maternal SE was partially
improved as SE became more remote. The antioxidant activity of
renal mitochondrial SOD in SE offspring was also significantly
reduced at P1 (P 0.05; Fig. 2B) and week 13 (P 0.01; Fig. 2F)
but not at P20 (Fig. 2D), confirming the impaired mitochondrial
ability of ROS clearance in SE offspring’s kidneys at birth and
adulthood. LC treatment significantly attenuated the reduction of
renal MnSOD and GPx-1 in both cytosolic and mitochondrial
fractions at P1 (P  0.05; Fig. 2A) as well as MnSOD in the
mitochondrial fraction at week 13 (P  0.05; Fig. 2E) in SE
offspring. Similarly, it also reversed renal mitochondrial SOD
activities at both P1 (P  0.01; Fig. 2B) and week 13 (P 
0.05; Fig. 2F). However, in P20 offspring, LC showed no
significant effect (Fig. 2, C and D).
Levels of total and mitochondrial ROS were measured as
markers of oxidative stress. Kidney tissues were stained with
cell-ROX red and Mitotracker to identify ROS production and
localization. There were marked elevations of renal ROS at week
13 (P 0.001; Fig. 3A), which were consistent with the observed
reductions in MnSOD/GPx-1 expression and activity. The results
reflect a dysregulation of renal redox homeostasis in offspring due
to maternal SE. Furthermore, the correlation coefficient of cell-
ROX red and Mitotracker was significantly higher in kidneys of
SE offspring at P1 and week 13 (P  0.01; Fig. 3B), suggesting
that the majority of excessive ROS is likely derived from the
mitochondria. Interestingly, maternal SE had no effect on renal
ROS or mitochondrial ROS at P20 (Fig. 3, A and B). Renal
mitochondrial ROS levels were significantly reduced by LC in SE
offspring at P1 and week 13 (P  0.001; Fig. 3C). Interestingly,
LC significantly reduced total ROS at P1, P20, and week 13 (P
0.01) and mitochondrial ROS at P1 and week 13 compared with
controls (P  0.001 and P  0.05, respectively; Fig. 3C).
Maternal LC supplementation reversed renal mitochondrial
dysfunction in SE offspring. To investigate mitochondrial func-
tion, we assessed TOM20, a mitochondrial outer membrane
Fig. 3. Confocal laser scanning microscopy images of total and mitochondrial ROS staining in offspring kidneys. A: representative confocal images for CellRox
staining showing total ROS intensity. B: representative confocal images for Mitotracker and CellRox costaining showing that most ROS were localized within
or within close proximity to the mitochondria. C: quantitative representation of mean fluorescent intensities (MFI) for A and B. n  3. *P  0.05, **P  0.01,
and ***P  0.001 vs. control or as indicated.
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receptor for the translocation of cytosolically synthesized mi-
tochondrial preproteins, and OXPHOS complexes I–V, key
components of the mitochondrial respiratory chain for ATP
synthesis. Renal protein levels of TOM20 and OXPHOS com-
plexes I, III, and V were significantly reduced in SE offspring
at P1 (P  0.05; Fig. 4A), suggesting impaired mitochondrial
protein and ATP synthesis. These markers were restored by
P20 (Fig. 4B) but again reduced at week 13 (Fig. 4C), mirroring
the changes of renal mitochondrial SOD in SE offspring.
Maternal LC supplementation significantly restored renal lev-
els of mitochondrial TOM20 and OXPHOS complexes I–III
and V at P1 (Fig. 4A). However, no impact was observed at
Fig. 4. Renal translocase of the outer membrane 20 (TOM20) and oxidative phosphorylation (OXPHOS) complex I–V (COX I–V) levels in offspring from
control, SE, and SE  LC groups at P1 (A), P20 (B), and week 13 (C). n  4–8. *P  0.05; **P  0.01; ***P  0.001.
F694 L-CARNITINE AND KIDNEY DISEASE IN OFFSPRING
AJP-Renal Physiol • doi:10.1152/ajprenal.00417.2014 • www.ajprenal.org
P20 (Fig. 4B). At week 13, offspring from LC-treated SE
mothers had normalized TOM20 and OXPHOS complexes I,
II, and V (P  0.01; Fig. 4C), suggesting a long-term effect of
LC to prevent mitochondrial dysfunction by maternal SE.
DISCUSSION
We have previously determined that maternal SE before and
during gestation and lactation induces renal underdevelopment
and impaired function in male offspring, although no signifi-
cant glomerular structural changes and interstitial abnormali-
ties were detected (1). In the present study, we demonstrated
that maternal SE can significantly increase renal oxidative
stress and impair mitochondrial function in offspring at birth
and adulthood. Supplementation of LC from gestation and
throughout lactation can effectively restore renal oxidative
homeostasis and mitochondrial function in SE offspring as well
as intrauterine growth retardation.
In the present study, SE offspring had reduced body weight
and kidney weight at birth, which is consistent with results
from a human epidemiology study (5). In addition, maternal SE
induced glucose intolerance and albuminuria in offspring from
SE mothers. Moreover, SE offspring showed reduced renal
levels of MnSOD and GPx-1, two vital enzymes for intracel-
lular antioxidant defense, especially within the mitochondria.
Encoded by genomic DNA, MnSOD is uniquely activated in
mitochondria and is the only mitochondrial enzyme known to
convert O2 into H2O2, resulting in ROS disposal (27). As such,
alternations in MnSOD quantity and activity can directly affect
mitochondrial antioxidant capacity. Unlike MnSOD, GPx-1
functions to convert H2O2 into H2O and O2 and can also be
modulated by several other enzymes, such as catalase or
peroxiredoxin. However, the reduction of GPx-1 in these
studies is evidence of impaired renal antioxidant capacity in
offspring by maternal SE. In addition, impaired mitochondrial
SOD activities and ROS accumulation provided direct evi-
dence for increased renal oxidative stress due to oxidant/
antioxidant imbalance in SE offspring.
The reduction of mitochondrial functional proteins, includ-
ing TOM20 and OXPHOS respiratory units, correlated with
increased oxidative stress. In addition, most of the excessive
ROS produced were derived from the mitochondria, as deter-
mined by dual staining of ROS and Mitotracker. This suggests
an important interplay between redox imbalance and mitochon-
drial dysfunction in the effector mechanisms of intrauterine SE
on offspring kidneys. It is well established that increased
oxidative stress can impair mitochondrial integrity (26), result-
ing in impaired mitochondrial preprotein import (30) and poor
energy metabolism (8). Conversely, mitochondrial dysfunc-
tion, such as defects in ATP exportation (12) and/or antioxi-
dant importation, may lead to an escalation of oxidative stress.
This is supported by the reduction of both mitochondrial
MnSOD and TOM20 in SE offspring kidneys at both P1 and
week 13. As the result of this dual effect, a cycle of oxidative
stress and mitochondrial damage/dysfunction is hypothesized
in SE offspring kidneys, which might significantly contribute
to kidney underdevelopment and/or the onset/progression of
renal-related disorders.
It is surprising that increased renal oxidative stress and
mitochondrial dysfunction were detected in SE offspring both
at birth and adulthood yet was mitigated at weaning. The
mechanism of this temporary recovery is unclear, and we can
only postulate that it may be due to the protective effect of
breast milk, which has been shown to be rich in antioxidants
(31). However, this protection was not sustained until adult-
hood. The persistent impact of maternal SE suggests that the
alteration may be related to epigenetic modifications in off-
spring kidneys that could not be reversed by the protective
effects of breastfeeding. This aspect warrants further investi-
gation.
It is well reported that LC supplementation can ameliorate
mitochondrial dysfunction and oxidative stress in diverse con-
ditions, including end-stage kidney disease (13). Here, we
showed that this treatment is also able to prevent similar
detrimental impacts by maternal SE in offspring kidneys not
just immediately at birth but also in the long term. Several
factors could have contributed to this effect. First, maternal
plasma LC levels during pregnancy are lower than normal,
which is supposedly linked to inadequate nutrient status (17).
Cigarette smoking during pregnancy has been associated with
reduced maternal micronutrient intake (22) and, hence, is likely
to contribute to the further reduction of LC availability in both
the mother and fetuses. Third, the kidney, being one of the
main sites of LC production, is likely to be sensitive to changes
in LC levels. It has been shown that LC can prevent renal
functional deterioration due to ischemia-reperfusion injury
(23). As LC is essentially involved in mitochondrial -oxida-
tion and has important secondary impacts on other metabolic
processes, low levels are likely to increase susceptibility to the
accumulation of harmful intermediaries (including ROS) and
dysregulate energy utilization (21), leading to oxidative stress
and mitochondrial dysfunction. Hence, it is unsurprising that
maternal LC supplementation partly reversed the effects of
maternal SE in offspring kidneys.
Our data demonstrated that LC significantly reduced total
ROS at all time points compared with control, confirming its
role as an antioxidant. Although LC significantly improved
antioxidant defenses in our study and reduced total and mito-
chondrial oxidative stress induced by maternal SE in offspring
kidneys, it is important to note that there is no evidence of its
direct effect on ROS scavenging. Unlike its well-studied role in
mitochondrial energy metabolism, the underlying mechanism
of its secondary antioxidative effect has not been elucidated
(14). Given the high correlation between increased oxidative
stress and mitochondrial dysfunction in this study, it is likely
that LC increases redox homeostasis through normalization of
mitochondrial energy metabolism. The theory is supported by
a previous study (10) showing that increasing mitochondrial
ATP synthesis is able to normalize ROS production in a
diabetic model.
In conclusion, our study demonstrates that maternal cigarette
SE leads to glucose intolerance and renal underdevelopment.
This was associated with renal oxidative stress and mitochon-
drial dysfunction in offspring at birth and adulthood. Impor-
tantly, these defects were significantly reversed by the maternal
supplementation of LC during gestation and lactation. This
study provides novel insights into abnormalities in mitochon-
drial function and increased oxidative stress that underpin the
adverse effects of maternal SE on renal pathology in offspring.
The study further suggests the potential for maternal LC
supplementation to limit the pathomechanistic processes that
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may predispose to the development of kidney disease in off-
spring of smoking mothers.
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